External validation of quality has never been more important for healthcare content creators. As generative AI increasingly powers healthcare queries and browser summaries, and media influencers sprea...

In this final edition of the weekly digest, we share practical guidance on navigating copyright in medical communications and explore why critical AI literacy is increasingly central to patient empowe...

This week, we highlight how Chiesi expanded copyright compliance and improved content access, understand the role of AI tools in fighting paper mill fraud, and read about STM group’s recommendations f...

This week, we look forward to the STM Research Integrity Day and celebrate the launch of Current Medical Research and Opinion’s Putting patients first article collection. We signpost an upcoming webin...

This week, we look ahead to COPE Publication Integrity Week 2025 and amplify the launch of the 2025 ORCID Global Participation Fund. We also celebrate the launch of Open Pharma Member Alfasigma’s new ...

This week, we spotlight the upcoming International Open Access Week 2025, which will focus on the theme of Who owns our knowledge? We signpost the latest Open Pharma guest post by Kora Korzec, which e...

Metadata of the DOI records registered with Crossref are a cornerstone of scholarly publishing, connecting research outputs through persistent, actionable links. In this post, I clarify what publicati...

This week, we share a survey seeking experiences with content reuse permissions, signpost an upcoming global discussion about OA publishing, and highlight an event at Cambridge University discussing i...

Traditional publishing practices are stifling global academic potential. Dependency on institutional subscriptions for access to academic literature and prolific use of ‘science speak’ hinders student...

This week, we listen to Amanda Solis and Leslie Rotz as they explain how to harness social media for medical research communication. We share a call for proposals for the 2026 NISO Plus conference and...

This week, we’re reflecting on Peer Review Week, which took place from 15 to 19 September and centred around the theme Rethinking peer review in the AI era. We begin by reading about new approaches to...

This week, we encourage readers to comment on draft OABP recommendations from NISO and complete a survey exploring how to make PLS clearer and more accessible. We also read guidance on how to make PLS accessible in APAC, and we consider when and how to retract an article. We review insights on transparent peer review based on experiences at the European Journal of Higher Education and ask if pharma is ready to rethink implementation for patient centricity. Finally, we listen to the latest MAPS Elevate podcast, which explores how to improve your journal selection process.

This week, we read about an AI screening tool developed to identify suspicious publishing practices, review evidence on the effectiveness of publication extenders, and examine concerns around the pote...

Social media is a powerful tool for science communication, allowing information to be shared at the speed of a swipe. Researchers, funders and communicators can use platforms such as Bluesky, Instagra...

Open Pharma and Bayer are proud to announce that Bayer has become the latest Supporter of Open Pharma! Open Pharma aims to drive positive change in the communication of research funded by the pharmace...

This week, we read about the OpenAIRE Graph and the steps we can take to make research and healthcare information more accessible to all. We highlight proposed solutions to improve the peer review pro...

This week, we explore how to collaborate effectively while using genAI, how genAI can enhance data sharing practices, and how the NIH is approaching its newly announced top priorities and funding revi...

This week, we explore the impact of article extenders on the readership of PLSPs and CTPs, and we review a critique of Nature’s decision to only publish peer review reports for accepted papers. We als...

This week, we read about improving incentives for peer reviewers, the author–editor networks that are used to publish fraudulent research and the gaming of the scientific system through strategic mani...

This week, we learn about NIH’s AI breakthrough in gene set analysis and highlight the importance of null results in the advancement of scientific discovery. We explore ORCID’s role in the evolving re...

This week, we explore how shortform science videos might be compromising our critical thinking. We read about how copyright regulations are changing with AI, and whether an AI jury could help improve ...

A group of publishers, in collaboration with The Synergist, are working together to create The PLS Finder – a comprehensive aggregator of abstract style plain language summaries (PLS) and standalone p...

This week, we reimagine ePI to transform the way we access and understand medical information and we read about Frontiers’ use of AI tools to check publication integrity. We also consider the importan...

This week, we highlight a new study from STM designed to understand how publishers safeguard publishing integrity and signpost the call for submissions to the 2026 Researcher to Reader Conference. We ...

This week, we listen to Conor Grennan as he explains why we should all ditch our trusty AI prompt libraries and just talk to AI like a person instead. We read the latest Open Pharma quarterly update a...

Open Pharma quarterly update: April–June 2025. Read about what we've been up to this quarter!

This week, we signpost STM’s roadmap for implementing the UN’s 17 Sustainable Development Goals in academic publishing. We read about what meaningful accessibility means in academic publishing, and we...

This week, we signpost an opportunity to contribute to NISO AI interoperability standards, feature a webinar about AI author tools at Springer Nature and include a reminder to register for the HIMSS A...

This week, we encourage you to contribute to two surveys about open access and AI tools in research communication. We learn about Elsa – the new AI tool developed by the US FDA – and read our latest b...

This week, we look ahead to a series of 10 virtual symposia taking place in the weeks leading up to Metascience 2025 and reflect on the 2025 Annual Meeting of ISMPP. We also read about how research fu...

This week, we signpost a survey seeking input on the future of open access publishing and a webinar on how efforts to improve researcher identification could help combat research misconduct. We read a...

This week, we welcome Alfasigma to Open Pharma and highlight 10 must-reads for transparent and reproducible pharmacoepidemiology research. We read about Springer Nature’s donation of a tool to spot AI...

We all recognize that, without transparency, trust in research evidence can falter. Most of us, therefore, feel a responsibility to increase the transparency and reproducibility of our work. However, ...

Open Pharma is proud to announce that Alfasigma has become the latest Member of Open Pharma.

This week, we spotlight a call for increased transparency in pharmacoepidemiology research and the barriers to publishing PLS. We read about the intersection of AI and open science principles, and we ...

Pharmacoepidemiology is at a crossroads. With the increasing availability of large healthcare datasets, transparent research practices are essential for maintaining trust and ensuring scientific valid...

This week, we signpost the Open Pharma activities at the 2025 Annual Meeting of ISMPP and reflect on our workshop at the Researcher to Reader Conference in February. We also read about how journal edi...

In a crowded online world, we need clear, concise, reliable scientific information to make informed decisions about our research, environment and health. The Open Pharma workshop 'More power to the re...

This week, we launch our HCP OA survey and read the latest Open Pharma guest article about the United2Act initiative to protect research integrity. We also learn about cases of journals stealthily edi...

Paper mills are infiltrating medical literature at an alarming rate, threatening evidence-based medicine, risking patient safety and undermining pharmaceutical innovation. This article examines how th...

This week, we learn about the importance of plain language summaries from the ISMPP podcast, In Plain Cite. We signpost an upcoming webinar about Registered Reports, and we feature a nine-part trainin...